Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1981-09-21
1985-07-23
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
206510, A61K 3910
Patent
active
045308322
ABSTRACT:
Viable cells of an avirulent self-clearing strain of B. bronchiseptica are administered as an intra-respiratory vaccine. An aqueous suspension of the cells is applied to the respiratory mucosa immediately after incorporating a non-inhibitory amount of a wetting agent promoting the mucosal implantation of the cells. Effective immunization can thereby be obtained against diseases such as kennel cough in dogs and atrophic rhinitis in swine even through the strain of B. bronchiseptica is so highly attenuated that it is self-clearing from the respiratory mucosa.
REFERENCES:
patent: 3384544 (1968-05-01), Walton et al.
patent: 3567585 (1971-03-01), Bloch et al.
patent: 3607858 (1971-09-01), Querry et al.
patent: 4225583 (1980-09-01), Switzer et al.
Goodnow Robert A.
Shade Floyd J.
Sloboth Thomas A.
Miller Stephen I.
Mosoff Serle I.
Rose Shep K.
Schering Corporation
LandOfFree
Method of vaccination for prevention of Bordetella bronchiseptic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of vaccination for prevention of Bordetella bronchiseptic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of vaccination for prevention of Bordetella bronchiseptic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-634148